Attention www.globalkeysolutions.net is now www.keypedia.com, read the full press release here.
KeyPedia LogoKeyPedia Icon
  1. Home
  2. /
  3. Records
  4. /
  5. Warning Letter
  6. /
  7. Dr. Garber’s Natural Solutions
WARNING LETTER
•Dr. Garber’s Natural Solutions•February 19, 2021

Dr. Garber’s Natural Solutions – FDA Warning Letter, Feb 19, 2021

Record Details

The FDA reviewed Dr. Garber's website, www.drgarbers.com, in January and February 2021 and determined that the "Dr. Garber's Depression Relief" product is marketed as a drug intended for the cure, mitigation, treatment, or prevention of disease, based on website claims. This product is considered a "new drug" under section 201(p) of the Federal Food, Drug, and Cosmetic Act (the Act) because it is not generally recognized as safe and effective for its intended uses. Introducing or delivering this product into interstate commerce without prior FDA approval violates sections 301(d) and 505(a) of the Act.

Furthermore, the product is deemed misbranded under section 502(f)(1) of the Act because it fails to bear adequate directions for its intended use. As a product intended for diseases not amenable to self-diagnosis or treatment, it requires supervision by a licensed practitioner, making it impossible to provide adequate directions for layperson use. The introduction or delivery of this misbranded drug into interstate commerce violates section 301(a) of the Act.

The letter states that these are not the only violations and that the firm is responsible for investigating and preventing recurrence. Prompt action is required to address these violations, as failure to do so may result in legal action, including seizure and injunction. Dr. Garber must notify the FDA in writing

Company
Dr. Garber’s Natural Solutions
Inspection date
February 19, 2021
Product type
Food
Office
Center for Food Safety and Applied Nutrition
Person
  • William A. Correll (Director)
View Company Profile

ID · 7e4fa5d0-7490-49e4-9a61-ebbd77e6079b

Violation Codes8
21 U.S.C. 331(a)21 U.S.C. 321(g)(1)(B)21 U.S.C. 321(p)21 U.S.C. 331(d)21.U.S.C. 355(a)21 U.S.C. 352(f)(1)21 CFR 201.521 U.S.C. 353(b)(1)(A)

Full citation text and observation details available on the Dashboard.

Your cart

Your cart is empty.

Browse public document pages and click Buy this document. We'll ask for your email at checkout, no account needed up front.

Browse documents

Discuss this record with AI

KeyPedia

ChatGPT

Claude

Perplexity

Grok

Copilot

Document or profile

One record shows the event. A profile shows the pattern.

Buy this document for the source file and details behind this single event.

Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.

Explore Dr. Garber’s Natural Solutions
KeyPedia
Regulatory Data Transformed
Stay in the loop

KRA score changes, company updates and news. About monthly, unsubscribe anytime.

Contact
New York Office:
370 Jay Street 7th Floor
Brooklyn, NY 11201
Scranton Office:
Scranton Enterprise Center, Suite 217
201 Lackawanna Avenue
Scranton, PA, 18503
🇺🇸+1 917-789-5099
🇪🇺+48 532-447-507
info@keypedia.com
Quick Links
HomePlatform OverviewMedia
KeyPedia™ Lite
Browse HubDatabase DirectoryRecordsCompaniesOfficesPeopleCareersAbout UsFounding TeamMeet Our ExpertsPartners
Legal & Ethics
Privacy PolicyTerms of ServiceOur Values & MissionCode of Ethics & AI Policy
©2026 KeyPedia™ | Global Key Solutions Corp. All rights reserved.